Literature DB >> 19454516

The sentinel node in cervical cancer patients: role of tumor size and invasion of lymphatic vascular space.

Petros Zarganis1, Agatha Kondi-Pafiti, Petroula Arapantoni-Dadioti, Erasmia Trivizaki, Konstantinos Velentzas, George Vorgias, Stelios Fotiou.   

Abstract

BACKGROUND: The sentinel lymph node (SLN) technique aims at predicting the absence of regional nodal metastasis and seems promising in the management of cervical cancer patients. PATIENTS AND METHODS: Forty patients undergoing surgery for early cervical cancer were submitted to the SLN procedure, using Blue Patente alone in 3, radiocolloid injection alone in 4 and both methods in 33 (82.5%). All patients underwent radical hysterectomy and pelvic lymphadenectomy.
RESULTS: The detection rate was as follows: overall 85%, blue dye alone 66%, radiocolloid alone 75%, dual method 87%. Detection was successful in 34 patients, with one false-negative result. No micrometastases were demonstrated during ultrastaging of the sentinels. The detection rate was higher in tumors <2 cm (94.1%) than in larger tumors (78.2%, p>0.09). Significant negative correlation between lymphatic vascular space invasion (LVSI) and detection rate was found (p<0.001).
CONCLUSION: SLN detection is feasible in early cervical cancer but presence of LVSI and a tumor size >2 cm negatively affect the detection rate and may increase the incidence of false negatives.

Entities:  

Mesh:

Year:  2009        PMID: 19454516

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  8 in total

Review 1.  Sentinel lymph node evaluation in women with cervical cancer.

Authors:  Laura L Holman; Charles F Levenback; Michael Frumovitz
Journal:  J Minim Invasive Gynecol       Date:  2014-01-07       Impact factor: 4.137

2.  Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.

Authors:  Gloria Salvo; Pedro T Ramirez; Charles F Levenback; Mark F Munsell; Elizabeth D Euscher; Pamela T Soliman; Michael Frumovitz
Journal:  Gynecol Oncol       Date:  2017-02-08       Impact factor: 5.482

3.  The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers.

Authors:  Francesco Giammarile; M Fani Bozkurt; David Cibula; Jaume Pahisa; Wim J Oyen; Pilar Paredes; Renato Valdes Olmos; Sergi Vidal Sicart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-08       Impact factor: 9.236

Review 4.  Sentinel-lymph-node procedures in early stage cervical cancer: a systematic review and meta-analysis.

Authors:  Xiao-Juan Wang; Fang Fang; Ye-Fei Li
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

5.  A Comparison of Radiocolloid and Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients with Cervical Cancer Undergoing Laparoscopic Surgery.

Authors:  Sara Imboden; Andrea Papadia; Mélina Nauwerk; Brett McKinnon; Zahraa Kollmann; Stefan Mohr; Susanne Lanz; Michael D Mueller
Journal:  Ann Surg Oncol       Date:  2015-06-30       Impact factor: 5.344

6.  Application of carbon nanoparticles in laparoscopic sentinel lymph node detection in patients with early-stage cervical cancer.

Authors:  Yan Lu; Jin-Ying Wei; De-Sheng Yao; Zhong-Mian Pan; Yao Yao
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

7.  The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.

Authors:  Ju-Hyun Kim; Dae-Yeon Kim; Dae-Shik Suh; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  World J Surg Oncol       Date:  2018-03-09       Impact factor: 2.754

8.  Clinical Study of Sentinel Lymph Node Detection to Evaluate Pelvic Lymph Node Metastasis to Determine the Prognosis of Patients with Early Cervical Cancer.

Authors:  Peipei Li; Shuai Feng; Guodong Zhou; Lu Zhang; Xiugui Sheng; Dapeng Li
Journal:  Appl Bionics Biomech       Date:  2022-03-23       Impact factor: 1.781

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.